AAAAAA
Results:
1-12
|
Results: 12
Authors:
BASSAN R
RAIMONDI R
LEREDE T
DEMILIO A
BUELLI M
BORLERI G
PERSONENI A
BELLAVITA P
RODEGHIERO F
BARBUI T
Citation: R. Bassan et al., OUTCOME ASSESSMENT OF AGE GROUP-SPECIFIC (+ -50 YEARS) POSTREMISSION CONSOLIDATION WITH HIGH-DOSE CYTARABINE OR BONE-MARROW AUTOGRAFT FOR ADULT ACUTE MYELOGENOUS LEUKEMIA/, Haematologica, 83(7), 1998, pp. 627-635
Authors:
BASSAN R
LEREDE T
BUELLI M
BORLERI G
BELLAVITA P
RAMBALDI A
BARBUL T
Citation: R. Bassan et al., A NEW COMBINATION OF CARBOPLATIN, HIGH-DOSE CYTARABINE AND CROSS-OVERMITOXANTRONE OR IDARUBICIN FOR REFRACTORY AND RELAPSED ACUTE MYELOID-LEUKEMIA, Haematologica, 83(5), 1998, pp. 422-427
Authors:
BASSAN R
CHIODINI B
ZUCCHETTI M
LEREDE T
CORNELLI PE
CORTELAZZO S
BARBUI J
Citation: R. Bassan et al., SHORT-COURSE INFUSIONAL IDARUBICIN PLUS INTERMITTENT CYTARABINE AND ETOPOSIDE FOR REFRACTORY HEMATOLOGIC MALIGNANCIES - CLINICAL AND PRELIMINARY PHARMACOLOGICAL RESULTS, Haematologica, 83(1), 1998, pp. 27-33
Authors:
BASSAN R
LEREDE T
DIBONA E
ROSSI G
POGLIANI E
RAMBALDI A
BUELLI M
VIERO P
RODEGHIERO F
IZZI T
CORNEO G
BARBUI T
Citation: R. Bassan et al., GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF, FILGRASTIM) AFTER OR DURING AN INTENSIVE REMISSION INDUCTION THERAPY FOR ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - EFFECTS, ROLE OF PATIENT PRETREATMENT CHARACTERISTICS, AND COSTS, Leukemia & lymphoma, 26(1-2), 1997, pp. 153-161
Authors:
BASSAN R
CHIODINI B
LEREDE T
TORRI V
BORLERI G
RAMBALDI A
BARBUI T
Citation: R. Bassan et al., THE ROLE OF IDARUBICIN IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - FROM DRUG-RESISTANCE STUDIES TO CLINICAL-APPLICATION, Leukemia & lymphoma, 26, 1997, pp. 89-97
Authors:
BASSAN R
DIBONA E
LEREDE T
POGLIANI E
ROSSI G
DEMILIO A
BUELLI M
RAMBALDI A
VIERO P
RODEGHIERO F
BARBUI T
Citation: R. Bassan et al., AGE-ADAPTED MODERATE-DOSE INDUCTION AND FLEXIBLE OUTPATIENT POSTREMISSION THERAPY FOR ELDERLY PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA, Leukemia & lymphoma, 22(3-4), 1996, pp. 295-301
Authors:
BASSAN R
LEREDE T
RAMBALDI A
DIBONA E
ROSSI G
POGLIANI E
LAMBERTENGHIDELILIERS G
PORCELLINI A
FABRIS P
BARBUI T
Citation: R. Bassan et al., THE ROLE OF ANTHRACYCLINES IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA, Leukemia, 10, 1996, pp. 58-61
Authors:
LEREDE T
BASSAN R
ROSSI A
DIBONA E
ROSSI G
POGLIANI EM
MOTTA T
TORRI V
BUELLI M
COMOTTI B
VIERO P
RAMBALDI A
CORTELAZZO S
RODEGHIERO F
BARBUI T
Citation: T. Lerede et al., THERAPEUTIC IMPACT OF ADULT-TYPE ACUTE LYMPHOBLASTIC-LEUKEMIA REGIMENS IN B-CELL L(3) ACUTE-LEUKEMIA AND ADVANCED-STAGE BURKITTS-LYMPHOMA/, Haematologica, 81(5), 1996, pp. 442-449
Authors:
BASSAN R
LEREDE T
BARBUI T
Citation: R. Bassan et al., STRATEGIES FOR THE TREATMENT OF RECURRENT ACUTE LYMPHOBLASTIC-LEUKEMIA IN ADULTS, Haematologica, 81(1), 1996, pp. 20-36
Authors:
BASSAN R
LEREDE T
RAMBALDI A
BARBUI T
Citation: R. Bassan et al., ROLE OF ANTHRACYCLINES IN THE TREATMENT OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA, Acta haematologica, 95(3-4), 1996, pp. 188-192
Authors:
BASSAN R
LEREDE T
BARBUI T
Citation: R. Bassan et al., INSTITUTIONAL PERFORMANCE AND DOSE INTENSITY AS PROGNOSTIC FACTORS INADULT ALL, Leukemia, 9(5), 1995, pp. 933-934
Authors:
BASSAN R
LEREDE T
RAMBALDI A
BUELLI M
VIERO P
BARBUI T
Citation: R. Bassan et al., THE USE OF ANTHRACYCLINES IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA, Haematologica, 80(3), 1995, pp. 280-291
Risultati:
1-12
|